Lumanity

Today is the final day of the ICPE 2024 annual meeting! If you haven't already, be sure to stop by booth 901 before the exhibit hall closes and connect with our colleagues, including Eline Houben, Jetty Overbeek, Josine Kuiper, Naomi Boxall, Eleonora Iob, and Nikita Jeswani! #ICPE24 #epidemiology #pharmacoepidemiology #healthcaredata

Don't miss the poster currently on display at the International Society for Pharmacoepidemiology annual meeting, Characteristics of Patients with ATTR Amyloidosis and Methodological Approaches for Establishing Clinical Subtype in the Netherlands. #ICPE24 #epidemiology #pharmacoepidemiology #amyloidosis #ATTR #ISPEAnnual2024

Burden of illness (BOI) and unmet need are key considerations for HTA decision makers, but how do manufacturers assess these when bringing a new medical treatment to market? In the first of a new how-to series, Lumanity’s Matthew Woods explores the importance of understanding burden of illness and unmet need, as well as giving an overview of the key considerations when conducting reviews. Want to know more? Follow the link and download the guide. https://buff.ly/3Av6WQD #LumanityPerspectives #UnmetNeed #BOI #HEOR #HTA

If you're in Berlin at the International Society for Pharmacoepidemiology annual meeting, be sure to stop by exhibit booth 901, chat with our experts, and learn about some of our latest research. For the full list of our presentations at ICPE this week, visit https://buff.ly/3XjLrv2 #ICPE24 #epidemiology #pharmacoepidemiology #healthcaredata #ISPEAnnual2024

The International Society for Pharmacoepidemiology annual meeting is underway in Berlin! Don't miss all of our oral presentations and posters, including: Oral Presentations: - Target Trial Emulation with Real World Evidence: Regulatory Grade Pharmacoepidemiology in the SIGMA consortium - GP consultation for menstrual disorders after COVID-19 vaccination – a self-controlled cohort study based on healthcare data from the Netherlands - Impact of data source diversity on the distribution of key variables in cohorts of pregnancies extracted with the ConcePTION algorithm leveraging on a random forest imputation model - Unravelling Sex Disparities in Statin Dose Titration Patterns in Primary Care Posters: - Interim results from the VAC4EU Post-Authorization Safety Study (PASS) among recipients of the Pfizer-BioNTech COVID-19 (Comirnaty®) vaccine in Europe - Safety of the Janssen COVID-19 vaccine (JCOVDEN) using VAC4EU European Healthcare Data: Methods and Results of the Second Study Feasibility Assessment - Migration background and HbA1c Checks and Balances: a large routine care data study in the Netherlands - Readiness of electronic healthcare record data sources for rapid evaluation of safety signals of SARS-CoV-2 Vaccines in Europe: results from the Covid-19 Vaccine Monitoring project - Challenges of multi-country post-authorisation safety studies for surveillance of new medical products - Oral antihypertensives in hypertensive pregnancy and the association with fetal growth: a population-based cohort study - Characteristics of Patients with ATTR Amyloidosis and Methodological Approaches for Establishing Clinical Subtype in the Netherlands - Rates of SARS-CoV-2 breakthrough infection or severe COVID-19 and associated risk factors after primary and booster vaccination against COVID-19 in the Netherlands - Identifying and profiling patients with heart failure in a population-based cohort through linkage of primary and secondary care data - Factor XA Inhibitor-related major bleeding events in the Netherlands - Use of SGLT2 Inhibitors in Patients With Type 2 Diabetes and Chronic Kidney Disease – a Multi-Country Report from the FOUNTAIN Platform - Exploring sources of statistical heterogeneity in a multi-database observational study: results from a case study using EXACOS-CV Connect with our staff while in Berlin, including Eline Houben, Jetty Overbeek, Josine Kuiper, Naomi Boxall, Eleonora Iob, PhD, and Nikita Jeswani, and don't forget to stop by exhibit booth 901! Learn more about the conference and the program agenda at https://buff.ly/3Me8ukN #ICPE2024 #pharmacoepidemiology #epidemiology #RWE #RWD #SafetyStudies #Amyloidosis #SIGMAConsortium #ISPEAnnual2024

We are delighted to announce the arrival of our insight team’s second graduate intake of the year. Welcome Aimee Walters, Patrick Abbott, Megan Brown, and Andrei Munteanu, who have chosen to embark on their careers with us in the dynamic field of market research. We are thrilled to have them on our team, and are eager to support their growth as they develop expertise in qualitative research, quantitative research, and social media analytics and insights. Our new graduates are already immersed in their inductions, getting acquainted with colleagues across the business, and contributing to solving our clients' challenges and delivering exceptional value. Welcome aboard! We look forward to achieving great things together. #MarketResearch #CareerGrowth #NewTalent #WeAreLumanity #ProfessionalDevelopment

#ICYMI: Our webinar “Oncology 2050: Have we been thinking of cancer management the right way” is available on-demand. Hear from industry experts on the paradigms of cancer management, treatment, business models, and more. https://buff.ly/4fM105T #ThoughtLeadership #CancerProgress #Oncology #OnDemandWebinar

We're proud to be a Gold sponsor and an exhibitor at the annual International Society for Pharmacoepidemiology meeting this week! Be sure to connect with our staff on site, including Eline Houben, Jetty Overbeek, Josine Kuiper, Naomi Boxall, Eleonora Iob, PhD, and Nikita Jeswani, and don't miss all of our presentations, including one workshop, two oral presentations, and 10 posters! Reach out to our on-site staff or stop by booth 901 during the conference. See you soon! #ICPE24 #epidemiology #pharmacoepidemiology #RWE #RWD #healthcaredata

The Inflation Reduction Act (IRA) may transform the generic drug market and impact cost savings. Discover how CMS price negotiations and market access challenges could reshape the landscape. Don't miss our new whitepaper on the potential impact of the IRA on generics. Read the full whitepaper now: https://buff.ly/3SVEQ7y #GenericDrugs #InflationReductionAct #IRA

This year's European Society of Cardiology (ESC) Congress is just around the corner and we can't wait! If you're attending the Congress in London, reach out to [email protected] to schedule a meeting with our attendees on-site. https://buff.ly/3AFegcn #ESCCongress